Related Experiment Video

Updated: Nov 28, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

15.2K

MicroRNA Regulation of TRAIL in Renal Carcinoma: Tiny Juggernauts at Work

Zeeshan Javed1, Khushbukhat Khan2, Haleema Sadia3

  • 1Office for Research Innovation and Commercialization (ORIC) Lahore Garrison University, Sector-c phase VI, DHA, Lahore, Pakistan.

Current Molecular Pharmacology
|November 26, 2020
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in renal carcinoma (RC) progression and survival. Targeting specific miRNAs offers a promising therapeutic strategy to enhance apoptosis and treat advanced RC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Renal Carcinoma (RC) is a significant cancer in men, with complex biological mechanisms driving its development and metastasis.
  • MicroRNAs (miRNAs) are increasingly recognized as critical regulators of cellular processes in RC, including proliferation, invasion, and apoptosis.
  • Dysregulation of miRNAs and their impact on pathways like TRAIL-mediated apoptosis are central to RC pathogenesis.

Purpose of the Study:

  • To discuss RC-specific microRNAs and their regulatory roles in the tumor microenvironment.
  • To elucidate the involvement of miRNAs in the TRAIL-mediated apoptotic pathway in renal cancer.
  • To identify potential diagnostic biomarkers and therapeutic targets among dysregulated miRNAs for advanced and metastatic RC.

Main Methods:

  • Review of current scientific literature on microRNAs in renal carcinoma.
  • Analysis of the role of specific miRNAs in regulating key cancer mechanisms.
  • Examination of the interplay between miRNAs and the TRAIL apoptotic pathway.

Main Results:

  • MicroRNAs play a crucial role in modulating RC development, progression, invasion, and metastasis.
  • Dysregulated miRNAs negatively impact apoptosis in cancer cells, promoting tumor survival and growth.
  • Specific miRNAs are implicated in hindering the TRAIL-mediated apoptotic pathway in renal cancer cells.

Conclusions:

  • MicroRNAs are pivotal in RC biology and represent viable therapeutic targets.
  • Targeting tumor-suppressive miRNAs to restore apoptosis is a promising strategy for advanced and metastatic RC.
  • Identifying specific miRNAs can lead to novel diagnostic biomarkers and therapeutic interventions for renal carcinoma.
Keywords:
MicroRNATRAILapoptosis.genitourinary cancersrenal carcinomatherapeutic targets

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K
Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K